Investigating the effect of rifaximin tablets on the quality of life and symptoms of irritable bowel syndrome in patients

Arak University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2023年2月7日

适应症

试验速览

暂无简介。

•Normal body mass index (18-25)
•Absence of any organic intestinal disease (diagnosis based on colonoscopy in the last 5 years) and absence of any intestinal infection (diagnosis based on stool culture)
•Absence of any major intestinal surgery
•Not taking laxatives or antidiarrheal drugs regularly
•Lack of medical history of gastrointestinal and colorectal diseases and absorption
•Lack of regular use of antibiotics and corticosteroids and immunosuppressive drugs
•Not taking drugs that increase bleeding from intestinal mucus such as aspirin, warfarin
•Absence of severe mental and behavioral disorder
•Not being pregnant or breastfeeding, being an athlete or being hospitalized
•Not taking non-steroidal anti-inflammatory drugs
•Absence of breast cancer in the person herself or first degree relatives

•Taking rifaximin tablets from one year before entering the study and changing the diet during the study
•Failure to continue the study due to drug side effects
•Reluctance to cooperate
•Pregnancy during study

发起方